Mammalian Cell Fermentation Technology Market is projected to grow from USD 50.50 billion in 2025 to USD 144.08 billion by 2036, at a CAGR of 10.0%. Chinese Hamster Ovary will dominate with a 46.7% type share, while Monoclonal Antibodies will dominate with a 52.4% application share, and Biopharmaceutical Companies will dominate with a 58.9% end share.